(Total Views: 385)
Posted On: 02/26/2021 1:18:43 PM
Post# of 153903
Viridi,
I believe the FDA and the developers of all these therapeutics are all searching for any subset of patients and treatment protocol which will benefit shareholders and the public.
Certainly, it is a challenge as Relief found with aviptadil. I am surprised and pleased that the FDA is belatedly assisting in this process. Good news for the public and relief shareholders.
I believe you are absolutely correct that both are likely try. The search for additional efficacy at 60 days does not indicate lack of efficacy at 28 days.
Thank you reminding me that these are not mutually exclusive.
I believe the FDA and the developers of all these therapeutics are all searching for any subset of patients and treatment protocol which will benefit shareholders and the public.
Certainly, it is a challenge as Relief found with aviptadil. I am surprised and pleased that the FDA is belatedly assisting in this process. Good news for the public and relief shareholders.
I believe you are absolutely correct that both are likely try. The search for additional efficacy at 60 days does not indicate lack of efficacy at 28 days.
Thank you reminding me that these are not mutually exclusive.
(4)
(0)
